ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS AND ULTRASONIC SIGNS OF INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS

ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS AND ULTRASONIC SIGNS OF INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS

Rheumatoid arthritis (RA) is a systemic autoimmune rheumatic disease characterized by chronic inflammation of the synovial membrane and a wide range of extra-articular (systemic) manifestations. The main goal of RA therapy is to achieve low disease activity or clinical remission. Power Doppler (PD)...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. G. Alekseeva, M. V. Severinova, N. V. Demidova, E. N. Aleksandrova, A. A. Novikov, E. L. Luchikhina, D. E. Karateev, A. V. Volkov, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2016-02-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis activity indices ultrasound study power doppler remission
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2149
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE TIME COURSE OF CHANGES IN BIOMARKER LEVELS AND THE ULTRASONIC SIGNS OF INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: O. G. Alekseeva, et al.
Published: (2015-10-01)

ASSOCIATION BETWEEN ULTRASOUND SIGNS OF JOINT INFLAMMATION AND RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: O. G. Alekseeva, et al.
Published: (2016-07-01)

POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY
by: E. L. Luchikhina, et al.
Published: (2016-12-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice?
by: V. N. Amirjanova, et al.
Published: (2022-07-01)

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-12-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES
by: E. L. Nasonov
Published: (2016-12-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

The Role of Musculoskeletal Ultrasound in Biologic Drug Tapering and Relapse Monitoring: Findings from a One-Year Prospective Study in a Cohort of Rheumatoid Arthritis Patients in Sustained Clinical Remission
by: Zguro Batalov, et al.
Published: (2025-07-01)

Efficacy and safety of Tofacitinib in patients with active rheumatoid arthritis resistant to conventional therapy: Preliminary results of an open-label clinical trial
by: E. L. Luchikhina, et al.
Published: (2016-06-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

USE OF MULTIPARAMETER ANALYSIS OF LABORATORY BIOMARKERS TO ASSESS RHEUMATOID ARTHRITIS ACTIVITY
by: A. A. Novikov, et al.
Published: (2016-02-01)

CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01)

Multiparameter analysis of biomarkers in the laboratory diagnosis of early rheumatoid arthritis
by: Aleksandr Aleksandrovich Novikov, et al.
Published: (2013-04-01)

LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
by: Natalya Vladimirovna Chichasova, et al.
Published: (2010-06-01)

AN ASSOCIATION OF CYTOKINE LEVELS WITH DISEASE ACTIVITY, AUTOANTIBODY LEVELS, AND JOINT DESTRUCTIVE CHANGES IN EARLY RHEUMATOID ARTHRITIS
by: A. S. Avdeeva, et al.
Published: (2015-09-01)

EFFICACY OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO ITS SERUM LEVEL AND THE PRESENCE OF ANTI-DRUG ANTIBODY
by: A. S. Avdeeva, et al.
Published: (2014-12-01)

Metabolic aspects of clinical remission prediction from baseline blood gene expression in patients with rheumatoid arthritis treated with methotrexate
by: E. V. Chetina, et al.
Published: (2019-05-01)

Systemic manifestations of rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2013-02-01)

Difficult-to-treat rheumatoid arthritis. What is it?
by: A. V. Gordeev, et al.
Published: (2021-10-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

Stabilization of remission in patients with opioid depen dence: pharmacological and pharmacogenetic aspects
by: V. Ya. Palatkin, et al.
Published: (2016-12-01)

The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA)
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-04-01)

Current methods for laboratory diagnosis of rheumatoid arthritis
by: A A Novikov, et al.
Published: (2010-02-01)

The marked and rapid therapeutic effect of tofacitinib in combination with subcutaneous methotrexate in a rheumatoid arthritis patient with poor prognostic factors who is resistant to standard disease-modifying antirheumatic drugs and biologicals: A clinical case
by: N. V. Demidova, et al.
Published: (2016-03-01)

Variability of response to pharmacotherapy of naltrexone and guanfacin in patients with opioid dependence syndrome: pharmacogenetic aspect
by: V. Ya Palatkin, et al.
Published: (2019-12-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

Immunological effects of adalimumab in rheumatoid arthritis: Results of a Russian national study
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-06-01)

INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
by: I. A. Guseva, et al.
Published: (2016-03-01)

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Problems of low activity and remission in systemic lupus erythematosus
by: S. K. Soloviev, et al.
Published: (2019-05-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

TRENDS IN DISEASE ACTIVITY, FUNCTIONAL STATUS, AND RADIOGRAPHIC CHANGES IN EARLY RHEUMATOID ARTHRITIS: RESULTS OF A 5-YEAR FOLLOW-UP WITHIN THE RUSSIAN RADIKAL PROGRAM
by: Yu. A. Ermakova, et al.
Published: (2015-03-01)

TIME COURSE OF CHANGES IN BLOOD LIPID PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING TREAT-TO-TARGET ANTIRHEUMATIC THERAPY: ACCORDING TO 18-MONTH FOLLOW-UP FINDINGS
by: E. V. Udachkina, et al.
Published: (2016-07-01)

POLYMYALGIA RHEUMATICA
by: A. M. Satybaldyev, et al.
Published: (2018-05-01)

Interstitial lung disease as an extra-articular manifestation of rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2013-06-01)